Dr. Noel Duplantier with Hancock Women’s Center has announced that she will be the first practice in the New Orleans - Mississippi Gulf Coast region to offer her patients the revolutionary new procedure called MonaLisa Touch. The procedure is a fractional carbon dioxide (CO2) laser designed to address gynecologic health.
The MonaLisa Touch Laser treatment is the first laser being used for the treatment of vaginal atrophy, a condition affecting primarily menopausal women, breast cancer survivors and women who have undergone hysterectomies. Women who suffer from the condition known as vaginal atrophy typically complain of symptoms such as vaginal dryness and irritation, lack of moisture, painful intercourse, painful urination and loss of vaginal tone.
This article contains sponsored content.
The laser treatment is pain-free, performed in the office setting, taking just 2-3 minutes, and requires no anesthesia or medications. In addition, it offers improvements over current drug therapies and convenience for people unwilling or unable to use estrogen-containing medications. This minimally invasive, painless therapy is performed in three treatments spaced six weeks apart. Patients return to premenopausal vaginal health.
“Physicians currently have a limited number of treatment options, and many patients cannot use standard therapies. This is why I am so excited to be the first to offer this to women who suffer from these very common irritating vaginal issues,” says Dr. Duplantier.
Restores vaginal health with the “game changing” MonaLisa™ Touch Laser
Vaginal health issues are commonly seen in postmenopausal women, breast cancer survivors, especially when using Tamoxifen, and women who have had a hysterectomy. These may begin even earlier in the perimenopause for those over 35. The MonaLisa Touch treatment is particularly well suited for patients who cannot, or elect not to, receive estrogen therapy.
The treatment is designed to stimulate and promote the regeneration of collagen fibers and the restoration of hydration and elasticity within the vaginal epithelium and mucosa. The laser is able to release energy through a special pulse, and the laser energy heat penetrates to a depth that stimulates the synthesis of new collagen. This results in more thickness and rugation of the vaginal skin, increased moisture and improved lubrication, and decreased pH, all of which restores the vagina to a state similar to before menopause.
The first U.S. trial in 2014 was led by Dr. Mickey Karram, Director of Fellowship Program on Female Pelvic Medicine & Reconstructive Surgery, The Christ Hospital, Cincinnati, OH and Dr. Eric Sokol, Associate Professor of Obstetrics and Gynecology at the Stanford University Medical Center. “All the patients’ experienced overwhelmingly positive and immediate results,” said Dr. Karram.
The North American Menopause Society reports 20% to 45% of midlife and older women suffer from vulvovaginal atrophy, which causes lack of lubrication and results in painful intercourse. Also, 80% of female sufferers in the U.S. feel the condition negatively affects their lives while only 7% of healthcare practitioners had initiated a conversation about the situation.
For over 23 years Hancock Women’s Center has been providing comprehensive, high quality care to women. Their physicians are Board Certified and maintain a fellow standing with the ACOG. The clinic’s Nurse Practitioner is a Women’s Health Nurse Practitioner and had 6 years of experience in Labor and Delivery before joining our practice.
Hancock Women’s Center believes every woman is unique and they strive to provide a personalized approach to healthcare needs by offering a wide range of treatment options. “By forming a partnership with our patients we can achieve the best possible outcomes. Our providers evaluate and treat a wide range of women’s health issues for patients of all ages,” says Dr. Duplantier.